Position in PGEN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,734,566
-$11,711,541 QoQ
Shares Held
1,998,596
-57.0% QoQ
Ownership
0.561%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in PGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,682,018,247 across 354 Biotechnology names. PGEN ranks #153 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in PGEN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,734,566 | 1,998,596 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $19,446,107 | 4,652,179 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $383,817 | 116,662 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $474,622 | 334,241 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $472,539 | 317,141 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $423,989 | 378,563 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $327,943 | 345,204 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $431,610 | 273,171 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $370,670 | 255,635 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $342,927 | 255,916 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $444,977 | 313,365 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $231,725 | 201,501 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $211,350 | 199,388 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $303,044 | 199,372 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $426,882 | 201,360 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $266,172 | 198,636 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $425,812 | 201,807 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $7,093 | 1,912 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,585 | 1,921 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $12,152 | 1,864 | Shares | Defined | 2021-08-13 | |
| 2020-06-30 | $998 | 200 | Shares | Defined | 2020-08-24 | |
| No filing history on record for this holder in this stock. | ||||||